P-Glycoprotein Function at the Blood–Brain Barrier in Humans Can Be Quantified with the Substrate Radiotracer 11C-N-Desmethyl-Loperamide
暂无分享,去创建一个
Jeih-San Liow | Peter Herscovitch | Nicholas Seneca | Nobuyo Kimura | Sami S Zoghbi | Victor W Pike | Robert B Innis | P. Herscovitch | S. Zoghbi | J. Liow | V. Pike | R. Innis | N. Seneca | W. Kreisl | Nobuyo Kimura | C. Morse | Cheryl L Morse | William C Kreisl
[1] A. Schinkel,et al. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. , 1996, The Journal of clinical investigation.
[2] Shu-Feng Zhou,et al. An update on clinical drug interactions with the herbal antidepressant St. John's wort. , 2008, Current drug metabolism.
[3] P Bevan,et al. Phase I trial of XR9576 in healthy volunteers demonstrates modulation of P-glycoprotein in CD56+ lymphocytes after oral and intravenous administration. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[4] Jennifer L. Donovan,et al. Aripiprazole brain concentration is altered in P-glycoprotein deficient mice , 2009, Schizophrenia Research.
[5] C. Wandel,et al. Increased drug delivery to the brain by P‐glycoprotein inhibition , 2000, Clinical pharmacology and therapeutics.
[6] Roman Rouzier,et al. Phase II study of tariquidar, a selective P‐glycoprotein inhibitor, in patients with chemotherapy‐resistant, advanced breast carcinoma , 2005, Cancer.
[7] T. Fojo,et al. A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine , 2009, Clinical Cancer Research.
[8] M. Raichle,et al. Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] Yuichi Sugiyama,et al. Evaluation of in vivo P-glycoprotein function at the blood-brain barrier among MDR1 gene polymorphisms by using 11C-verapamil. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] Christopher M Waters,et al. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. , 2008, American journal of physiology. Cell physiology.
[11] M. Gottesman. Mechanisms of cancer drug resistance. , 2002, Annual review of medicine.
[12] Wolfgang Löscher,et al. Several major antiepileptic drugs are substrates for human P-glycoprotein , 2008, Neuropharmacology.
[13] Richard E Carson,et al. Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of 18F-paclitaxel in nonhuman primates. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] P. Herscovitch,et al. P-Glycoprotein Function at the Blood–Brain Barrier Imaged Using 11C-N-Desmethyl-Loperamide in Monkeys , 2008, Journal of Nuclear Medicine.
[15] R. Kramer,et al. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. , 1993, Cancer research.
[16] M. Fromm,et al. Importance of P-glycoprotein at blood-tissue barriers. , 2004, Trends in pharmacological sciences.
[17] Jeih-San Liow,et al. N-desmethyl-Loperamide Is Selective for P-Glycoprotein among Three ATP-Binding Cassette Transporters at the Blood-Brain Barrier , 2010, Drug Metabolism and Disposition.
[18] M. Hall,et al. Imaging the Function of P‐Glycoprotein With Radiotracers: Pharmacokinetics and In Vivo Applications , 2009, Clinical pharmacology and therapeutics.
[19] Michael J. Welch,et al. Imaging Multidrug Resistance P-glycoprotein Transport Function Using MicroPET with Technetium-94m-Sestamibi , 2005, Molecular imaging.
[20] Jeih-San Liow,et al. Human Brain Imaging and Radiation Dosimetry of 11C-N-Desmethyl-Loperamide, a PET Radiotracer to Measure the Function of P-Glycoprotein , 2009, Journal of Nuclear Medicine.
[21] Jeih-San Liow,et al. 11C-Loperamide and Its N-Desmethyl Radiometabolite Are Avid Substrates for Brain Permeability-Glycoprotein Efflux , 2008, Journal of Nuclear Medicine.
[22] Jeih-San Liow,et al. Synthesis and evaluation of [N-methyl-11C]N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp function. , 2008, Journal of medicinal chemistry.
[23] Gary M Pollack,et al. Modulation of P-glycoprotein Transport Activity in the Mouse Blood-Brain Barrier by Rifampin , 2003, Journal of Pharmacology and Experimental Therapeutics.
[24] R. P. Maguire,et al. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[25] Krzysztof Jamroziak,et al. Pharmacogenomics of MDR1/ABCB1 Gene: the Influence on Risk and Clinical Outcome of Haematological Malignancies , 2004, Hematology.
[26] R. Béliveau,et al. Cellular localization of P-glycoprotein in brain versus gonadal capillaries. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.